Among nearly 10 000 patients with maturity onset diabetes the use of fenofibrate to lower cholesterol produced a 24 per cent statistically significant reduction of cardiovascular events, but no reduction in the risk of death. Anthony Keech of University of Sydney told AHA delegates about his findings.
Reporting from:
American College of Cardiology Annual Scientific Session 2005, March 6-9, Orlando, Florida
In this edition:
Adnan Kastrati has found that a
HILARY SELIGMAN, University of California, San Francisco
REFERENCE: ABSTRACT Press Release, San Diego ACP 2007
Doctors can best help their patients with
Reporting from:
American College of Cardiology Annual Scientific Session 2005, March 6-9, Orlando, Florida
Scientific Editors:
Michael Petch, Papworth Hospital, Cambridge
Man Fai Shiu,
Post a comment